UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009593
Receipt number R000011254
Scientific Title Clinical effects of Goshajinkigan for overactive bladder in female patients and correlation between severity of OAB symptoms and coldness.
Date of disclosure of the study information 2012/12/20
Last modified on 2012/12/20 15:31:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical effects of Goshajinkigan for overactive bladder in female patients and correlation between severity of OAB symptoms and coldness.

Acronym

Clinical effects of Goshajinkigan for overactive bladder in female patients

Scientific Title

Clinical effects of Goshajinkigan for overactive bladder in female patients and correlation between severity of OAB symptoms and coldness.

Scientific Title:Acronym

Clinical effects of Goshajinkigan for overactive bladder in female patients

Region

Japan


Condition

Condition

Overactive bladder

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the benefit of Kampo-Goshajinkigan in female patietns with overactive bladder and correlation between the severity of OAB symptoms and coldness

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

OABSS

Key secondary outcomes

1)Symptom score of coldness
2)IPSS
3)Body temperature


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Goshajinnkigan 7.5g PO tid for 4 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1)Written informed consent
2)OABSS Q3 2<=, OABSS total score 3<=

Key exclusion criteria

1)On-going Kampo-therapy
2)Neurogenic bladder
3)Previous XRT therapy for whole pevis
4)UTI
5)Any other cases who are regarded as inadequate for study enrollment by the investigator

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toyohiko Watanabe

Organization

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Division name

Department of Urology

Zip code


Address

2-5-1, Shikata, Okayama 700-8558, Japan

TEL

086-235-7287

Email



Public contact

Name of contact person

1st name
Middle name
Last name Toyohiko Watanabe

Organization

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Division name

Department of Urology

Zip code


Address

2-5-1, Shikata, Okayama 700-8558, Japan

TEL

086-235-7287

Homepage URL


Email



Sponsor or person

Institute

Department of Urology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Institute

Department

Personal name



Funding Source

Organization

Department of Urology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山大学病院(岡山県),川崎医科大学附属病院(岡山県),倉敷成人病センター(岡山県),岡山労災病院(岡山県),しな子レディースクリニック(岡山県)


Other administrative information

Date of disclosure of the study information

2012 Year 12 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 11 Month 27 Day

Date of IRB


Anticipated trial start date

2012 Year 11 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 12 Month 20 Day

Last modified on

2012 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011254


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name